Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $48.2 million.

  • Upstream Bio's Cash from Investing Activities rose 331987.22% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$110.5 million, marking a year-over-year decrease of 363.76%. This contributed to the annual value of -$59.5 million for FY2024, which is 2819.46% up from last year.
  • Per Upstream Bio's latest filing, its Cash from Investing Activities stood at $48.2 million for Q3 2025, which was up 331987.22% from $12.8 million recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Cash from Investing Activities ranged from a high of $48.2 million in Q3 2025 and a low of -$213.4 million during Q1 2025
  • For the 3-year period, Upstream Bio's Cash from Investing Activities averaged around -$27.1 million, with its median value being $7.1 million (2024).
  • The largest annual percentage gain for Upstream Bio's Cash from Investing Activities in the last 5 years was 331987.22% (2025), contrasted with its biggest fall of 164043.46% (2025).
  • Over the past 3 years, Upstream Bio's Cash from Investing Activities (Quarter) stood at -$5.2 million in 2023, then skyrocketed by 899.47% to $41.9 million in 2024, then increased by 14.98% to $48.2 million in 2025.
  • Its Cash from Investing Activities was $48.2 million in Q3 2025, compared to $12.8 million in Q2 2025 and -$213.4 million in Q1 2025.